Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net loss	$ (3,537,661)	$ (1,551,589)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	37,608	35,376
Unrealized loss on marketable securities	4,137	(10,190)
Stock based compensation expense	1,614,845	0
Changes in assets and liabilities:
Accounts receivable	(3,114,265)	(146,804)
Inventory	(1,756,594)	(1,208,657)
Inventory deposits	(15,896)	(292,879)
Prepaid expenses	285,245	(1,950,600)
Other non-current assets	158,270	265,523
Accounts payable	28,023	(239,413)
Accrued liabilities	(330,100)	(1,800,582)
Other non-current liabilities	0	82,348
Net cash used in operating activities	(6,626,389)	(6,817,467)
Cash flows from investing activities:
Purchase of property and equipment, net	(52,471)	(183,076)
Investment in marketable securities	(2,003,909)	(12,000,000)
Sale of marketable securities	8,000,000
Cash acquired in merger	0	3,373,332
Net cash provided by (used in) investing activities	5,943,620	(8,809,744)
Cash flows from financing activities:
Proceeds from issuance of common stock	120,000	22,737,159
Payments for deferred offering costs	0	(188,015)
Principal advances from (repayments on) debt	(13,245)	(309,865)
Net cash provided by financing activities	106,755	22,239,279
Net change in cash, and restricted cash	(576,013)	6,612,067
Cash, restricted cash, and cash equivalents at the beginning of the period	4,906,525	1,930,132
Cash, restricted cash, and cash equivalents at the end of the period	4,330,512	8,542,199
Supplemental cash flow disclosures:
Cash paid for interest expense	1,227	$ 2,283
Cash paid for income taxes	0
Non-cash common stock lawsuit settlement, reverse stock split rounding	$ 199,162